Lilly Arthritis Treatment Lands FDA Approval
A once-daily treatment for rheumatoid arthritis being developed by Indianapolis-based Eli Lilly and Co. (NYSE: LLY) and Delaware-based Incyte Corp. (Nasdaq: INCY) has cleared a key hurdle. The U.S....... Read More
